Concepts (50)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 1 | 2023 | 101 | 0.200 |
Why?
|
| Influenza B virus | 1 | 2019 | 2 | 0.160 |
Why?
|
| Atypical Hemolytic Uremic Syndrome | 1 | 2019 | 2 | 0.160 |
Why?
|
| Membrane Cofactor Protein | 1 | 2019 | 3 | 0.160 |
Why?
|
| Plasma Exchange | 1 | 2019 | 16 | 0.160 |
Why?
|
| Influenza, Human | 1 | 2019 | 50 | 0.160 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2019 | 115 | 0.150 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2019 | 108 | 0.150 |
Why?
|
| Bortezomib | 1 | 2017 | 5 | 0.140 |
Why?
|
| Mutation | 1 | 2019 | 409 | 0.140 |
Why?
|
| Antibodies | 1 | 2017 | 67 | 0.140 |
Why?
|
| Graft Rejection | 1 | 2017 | 75 | 0.140 |
Why?
|
| Adolescent | 3 | 2023 | 2403 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 124 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2009 | 161 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2009 | 498 | 0.070 |
Why?
|
| Young Adult | 2 | 2023 | 2063 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2023 | 65 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2023 | 1898 | 0.040 |
Why?
|
| Trans-Activators | 1 | 1998 | 28 | 0.040 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 1998 | 9 | 0.040 |
Why?
|
| Interferon-alpha | 1 | 1998 | 68 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 1998 | 79 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2017 | 18 | 0.040 |
Why?
|
| Immune System | 1 | 2017 | 26 | 0.040 |
Why?
|
| Rituximab | 1 | 2017 | 55 | 0.040 |
Why?
|
| Midwestern United States | 1 | 2017 | 70 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 61 | 0.030 |
Why?
|
| Humans | 5 | 2023 | 31066 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 190 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 249 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 1998 | 274 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 1998 | 260 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2017 | 126 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 578 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 691 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2023 | 5192 | 0.030 |
Why?
|
| Child | 1 | 2017 | 1431 | 0.030 |
Why?
|
| Male | 2 | 2019 | 16495 | 0.020 |
Why?
|
| Adult | 1 | 2023 | 8949 | 0.020 |
Why?
|
| Middle Aged | 1 | 2023 | 10238 | 0.020 |
Why?
|
| Aged | 1 | 2023 | 10078 | 0.020 |
Why?
|
| Protein Binding | 1 | 2009 | 124 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 3809 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2017 | 3665 | 0.020 |
Why?
|
| Kidney | 1 | 2009 | 181 | 0.020 |
Why?
|
| Female | 1 | 2017 | 17016 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 1998 | 2 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 149 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1998 | 112 | 0.010 |
Why?
|